- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Crisis Management
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Marisa C. Maleck
News 20 results
In the News · Source: The Rutherford Institute
April 21, 2022
Marisa Maleck, Joshua Mitchell and Edward Benoit submit an amicus brief to the Supreme Court in a case about Fourth Amendment rights
In the News · Source: Law360
In the News · Source: Bloomberg Law and Law360
In the News · Source: Law360
January 12, 2022
Marisa Maleck, Anne Voigts and Kathryn Running advise Walmart before the Seventh Circuit
Events 7 results
Webinar
June 22, 2022
Navigating the Privacy and Security Landscape: Recent Developments and Best Practices for Life Sciences Companies
Webinar
May 18, 2022
Trending Now: Privacy and Cybersecurity Regulations
Webinar
November 9, 2021
King & Spalding Pharmaceutical University 2021
Webinar
April 27, 2021
What to Expect From the DOJ in the Biden Administration
Insights 7 results
Client Alert
October 18, 2021
HHS Continues Focus on Women's Health: AHRQ Calls for Data on Telehealth for Women
Client Alert
August 27, 2021
FDA Rejects Bids To Market CBD-Based Dietary Supplements
Newsletter
August 25, 2021
International Food Law Gazette – August 2021
Client Alert
February 2, 2021
USDA Issues Final Rule to Establish Domestic Hemp Production Program and Approve State and Tribal Oversight Plans